These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6859216)

  • 1. Altered growth patterns in vitro of human papillary transitional carcinoma cells.
    Reznikoff CA; Gilchrist KW; Norback DH; Cummings KB; Ertürk E; Bryan GT
    Am J Pathol; 1983 Jun; 111(3):263-72. PubMed ID: 6859216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary urothelial carcinoma of the urinary bladder demonstrating prominent signet-ring cells in a smear. A case report.
    Shinagawa T; Tadokoro M; Abe M; Koshitaka Y; Kouno S; Hoshino T
    Acta Cytol; 1998; 42(2):407-12. PubMed ID: 9568147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients.
    Harney J; Murphy DM; Jones M; Mothersill C
    Br J Cancer; 1995 Jan; 71(1):25-9. PubMed ID: 7819043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of Malakoplakia and Papillary Urothelial Carcinoma of the Urinary Bladder.
    Lee SL; Teo JK; Lim SK; Salkade HP; Mancer K
    Int J Surg Pathol; 2015 Oct; 23(7):575-8. PubMed ID: 26194600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
    Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
    Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whorled Urothelial Cell Carcinoma: A Neglected Variant.
    Patriarca C; Comperat E; Bollito E; Ussia A; Scola G; Cavallero A; Ferrari L; Giunta P; Conti G
    Int J Surg Pathol; 2014 Aug; 22(5):408-13. PubMed ID: 24651908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
    Moll R; Laufer J; Wu XR; Sun TT
    Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
    McKenney JK; Amin MB; Young RH
    Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal and vascular invasion in an human in vitro bladder cancer model.
    Booth C; Harnden P; Trejdosiewicz LK; Scriven S; Selby PJ; Southgate J
    Lab Invest; 1997 Jun; 76(6):843-57. PubMed ID: 9194860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
    Stewart GD; Bariol SV; Grigor KM; Tolley DA; McNeill SA
    BJU Int; 2005 Apr; 95(6):791-3. PubMed ID: 15794784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.